*First author publications

  1. Neelamraju Y.*, E. Gjini, S. Chhangawala, H. Fan, S. He, C. B. Jing, A. T. Nguyen, S. Prajapati, C. Sheridan, Y. Houvras, A. Melnick, A. T. Look and F. E. Garrett-Bakelman (2023). “Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.” Read it here

  2. Rapaport, F., K. Seier, Neelamraju Y.*, D. Hassane, T. Baslan, D. T. Gildea, S. Haddox, T. Lee, H. M. Murdock, C. Sheridan, A. Thurmond, L. Wang, M. Carroll, L. D. Cripe, H. Fernandez, C. E. Mason, E. Paietta, G. J. Roboz, Z. Sun, M. S. Tallman, Y. Zhang, M. Gonen, R. Levine, A. M. Melnick, M. Kleppe and F. E. Garrett-Bakelman (2022). “Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999.” Read it here

  3. Barreyro, L., A. M. Sampson, C. Ishikawa, K. M. Hueneman, K. Choi, M. A. Pujato, S. Chutipongtanate, et al. “Blocking Ube2n Abrogates Oncogenic Immune Signaling in Acute Myeloid Leukemia.”Read it here

  4. Rapaport F, Neelamraju Y, Baslan T, Hassane D, Gruszczynska A, Robert de Massy M, et al. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia. Leukemia. 2021.Read it here

  5. Olson TL, Cheon H, Xing JC, Olson KC, Paila U, Hamele CE, et al. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood. 2021;138(8):662-73.Read it here

  6. Abshiru NA, Sikora JW, Camarillo JM, Morris JA, Compton PD, Lee T, et al. Targeted detection and quantitation of histone modifications from 1,000 cells. PLoS One. 2020;15(10):e0240829.Read it here

  7. Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, et al. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019;20(2).Read it here

  8. Neelamraju Y.*, Gonzalez-Perez A, Bhat-Nakshatri P, Nakshatri H, Janga SC. Mutational landscape of RNA-binding proteins in human cancers. RNA Biol. 2018;15(1):115-29.Read it here

  9. Nishtala S, Neelamraju Y, Janga SC. Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks. Sci Rep. 2016; 6:25711.Read it here

  10. Neelamraju Y.*, Hashemikhabir S, Janga SC. The human RBPome: from genes and proteins to human disease. J Proteomics. 2015;127(Pt A):61-70.Read it here

  11. Hashemikhabir S, Neelamraju Y, Janga SC. Database of RNA binding protein expression and disease dynamics (READ DB). Database (Oxford). 2015;2015: bav072.Read it here

  12. Gokmen-Polar Y, Vladislav IT, Neelamraju Y, Janga SC, Badve S. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers. Sci Rep. 2015; 5:8765.Read it here

  13. Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu X, Nallamothu G, Janga SC, et al. Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer. Mod Pathol. 2015;28(5):677-85.Read it here

  14. Chaturvedi P, Neelamraju Y, Arif W, Kalsotra A, Janga SC. Uncovering RNA binding proteins associated with age and gender during liver maturation. Sci Rep. 2015; 5:9512.Read it here